Subtle Medical lands FDA clearance for AI CT imaging software

SubtleHD(CT) joins Subtle’s other AI medical imaging products including SubtlePET and SubtleHD(MR) that aim to improve PET and MR images, respectively. SubtleHD(CT) joins Subtle’s other AI medical imaging products including SubtlePET and SubtleHD(MR) that aim to improve PET and MR images, respectively. According to GlobalData analysis, the AI market across the healthcare sector is projected to reach a valuation of $57.4bn in 2029. Credit: Tada Images / Shutterstock.com Fresh off the back of closing a $33m financing round, Subtle Medical has received US Food and Drug Administration (FDA) clearance for its artificial intelligence (AI)-based software for improving computed tomography (CT)…

Source: Medical Device Network